These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 30927946)

  • 1. Unresectable pancreatic ductal adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting outcomes of patients treated with chemotherapy.
    Cheng SH; Cheng YJ; Jin ZY; Xue HD
    Eur J Radiol; 2019 Apr; 113():188-197. PubMed ID: 30927946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic melanoma: pretreatment contrast-enhanced CT texture parameters as predictive biomarkers of survival in patients treated with pembrolizumab.
    Durot C; Mulé S; Soyer P; Marchal A; Grange F; Hoeffel C
    Eur Radiol; 2019 Jun; 29(6):3183-3191. PubMed ID: 30645669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy.
    Yip C; Landau D; Kozarski R; Ganeshan B; Thomas R; Michaelidou A; Goh V
    Radiology; 2014 Jan; 270(1):141-8. PubMed ID: 23985274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.
    Borhani AA; Dewan R; Furlan A; Seiser N; Zureikat AH; Singhi AD; Boone B; Bahary N; Hogg ME; Lotze M; Zeh HJ; Tublin ME
    AJR Am J Roentgenol; 2020 Feb; 214(2):362-369. PubMed ID: 31799875
    [No Abstract]   [Full Text] [Related]  

  • 5. Visual enhancement pattern during the delayed phase of enhanced CT as an independent prognostic factor in stage IV pancreatic ductal adenocarcinoma.
    Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nagano H; Hidaka S; Kamimura K; Maemura K; Arima S; Yoshiura T
    Pancreatology; 2020 Sep; 20(6):1155-1163. PubMed ID: 32800574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced Hepatocellular Carcinoma: Pretreatment Contrast-enhanced CT Texture Parameters as Predictive Biomarkers of Survival in Patients Treated with Sorafenib.
    Mulé S; Thiefin G; Costentin C; Durot C; Rahmouni A; Luciani A; Hoeffel C
    Radiology; 2018 Aug; 288(2):445-455. PubMed ID: 29584597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer.
    Evans TRJ; Van Cutsem E; Moore MJ; Bazin IS; Rosemurgy A; Bodoky G; Deplanque G; Harrison M; Melichar B; Pezet D; Elekes A; Rock E; Lin C; Strauss L; O'Dwyer PJ
    Ann Oncol; 2017 Feb; 28(2):354-361. PubMed ID: 27998964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics Texture Features in Advanced Colorectal Cancer: Correlation with
    Negreros-Osuna AA; Parakh A; Corcoran RB; Pourvaziri A; Kambadakone A; Ryan DP; Sahani DV
    Radiol Imaging Cancer; 2020 Sep; 2(5):e190084. PubMed ID: 33778733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma.
    Oba A; Ban D; Kirimura S; Akahoshi K; Mitsunori Y; Matsumura S; Ochiai T; Kudo A; Tanaka S; Minoru T
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):480-8. PubMed ID: 27247050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection.
    Cai X; Gao F; Qi Y; Lan G; Zhang X; Ji R; Xu Y; Liu C; Shi Y
    Eur Radiol; 2020 Sep; 30(9):5158-5169. PubMed ID: 32346792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy.
    Salinas-Miranda E; Khalvati F; Namdar K; Deniffel D; Dong X; Abbas E; Wilson JM; O'Kane GM; Knox J; Gallinger S; Haider MA
    Can Assoc Radiol J; 2021 Nov; 72(4):605-613. PubMed ID: 33151087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes.
    Lubner MG; Stabo N; Lubner SJ; del Rio AM; Song C; Halberg RB; Pickhardt PJ
    Abdom Imaging; 2015 Oct; 40(7):2331-7. PubMed ID: 25968046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early decrement of serum carbohydrate antigen 19-9 predicts favorable outcome in advanced pancreatic cancer.
    Chung KH; Ryu JK; Lee BS; Jang DK; Lee SH; Kim YT
    J Gastroenterol Hepatol; 2016 Feb; 31(2):506-12. PubMed ID: 26250642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribonucleotide reductase M2 does not predict survival in patients with resectable pancreatic adenocarcinoma.
    Xie H; Lin J; Thomas DG; Jiang W; Liu X
    Int J Clin Exp Pathol; 2012; 5(4):347-55. PubMed ID: 22670179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study protocol for an open-label, single-arm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma.
    Shui L; Cheng K; Li X; Shui P; Zhou X; Li J; Yi C; Cao D
    BMC Cancer; 2020 Jul; 20(1):636. PubMed ID: 32646394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of Extracellular Volume Fraction With Routine Multiphasic Pancreatic Computed Tomography to Predict the Survival of Patients With Stage IV Pancreatic Ductal Adenocarcinoma.
    Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nakajo M; Maemura K; Arima S; Yoshiura T
    Pancreas; 2019; 48(10):1360-1366. PubMed ID: 31688602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor radiomic features complement clinico-radiological factors in predicting long-term local control and laryngectomy free survival in locally advanced laryngo-pharyngeal cancers.
    Agarwal JP; Sinha S; Goda JS; Joshi K; Mhatre R; Kannan S; Laskar SG; Gupta T; Murthy V; Budrukkar A; Mummudi N; Ganeshan B
    Br J Radiol; 2020 May; 93(1109):20190857. PubMed ID: 32101463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma - a quantitative analysis.
    Eilaghi A; Baig S; Zhang Y; Zhang J; Karanicolas P; Gallinger S; Khalvati F; Haider MA
    BMC Med Imaging; 2017 Jun; 17(1):38. PubMed ID: 28629416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular Carcinoma: Texture Analysis of Preoperative Computed Tomography Images Can Provide Markers of Tumor Grade and Disease-Free Survival.
    Oh J; Lee JM; Park J; Joo I; Yoon JH; Lee DH; Ganeshan B; Han JK
    Korean J Radiol; 2019 Apr; 20(4):569-579. PubMed ID: 30887739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study.
    Park SJ; Kim H; Shin K; Hong TH; Suh JH; Lee MA
    BMC Cancer; 2021 Nov; 21(1):1176. PubMed ID: 34732161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.